JP Morgan maintains Alignment Healthcare at Overweight, lowers price target to $8 from $10

JP Morgan kept Alignment Healthcare at Overweight but reduced its price target to $8 from $10, a 20% cut. The new target suggests a 10% upside from the Oct 30 close of $7.27. Recent analyst price targets for the company range from $9 to $12.

Original reporting
Published Oct 30, 2026, 11:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
JP Morgan maintains Alignment Healthcare at Overweight, lowers price target to $8 from $10 — source image
Decision brief

The 30-second read

$ALHCBearishLow
01

Why it matters

A 20% target cut may prompt short interest or sell pressure, but the effect is limited to the micro‑cap.

02

Market read

Analyst target change provides modest new information for traders of ALHC.

03

Timing

today

Relevance 5/10Novelty 4/10Timing: today

Background

The article reports a recent analyst action by JP Morgan on Alignment Healthcare.

Company-level read

Ticker impact

$ALHCBearishMedium confidence
Context

JP Morgan lowered its price target for Alignment Healthcare to $8 from $10, indicating a 20% reduction.

Expected impact

likely downward pressure as investors price in the lower target

Evidence & confidence

Target reduction is a fresh analyst action, but no new operational data accompanies it.

Key entities

  • Alignment Healthcare

    Micro‑cap healthcare firm covered by JP Morgan.

Related articles

$ALHCMedAI 8/10

Alignment Healthcare (ALHC) Q3 2026 Earnings Call Transcript

Alignment Healthcare (ALHC) reported Q3 2026 earnings, with revenue of $1.4B (up 37% YoY) and adjusted gross profit of $142M. The company lowered annual guidance due to higher costs, targeting adjusted gross profit of at least $575M and adjusted EBITDA of $100M. Membership grew 31% YoY to 301,200. ALHC is addressing cost pressures and investing in clinical programs for 2027 growth.

$ALHCMedAI 8/10

What Alignment Healthcare (ALHC) Said on Its Q3 Earnings Call

Alignment Healthcare (ALHC) reduced its 2026 outlook, expecting at least $5.25B revenue, $575M adjusted gross profit, and $100M adjusted EBITDA. Q4 forecasts include 305K membership, $1.32B revenue, and $104M gross profit. Management targets 20% top-line growth in 2027, with plans to enter new markets and improve care model scalability. Stars ratings and provider alignment remain focus areas.